Summary
The product Ment (30 mg), submitted by MuscleCandy, underwent qualitative and quantitative analysis. The batch is identified as Lot 1003, and the analysis detected a concentration of 29.75 mg/ml of Trestolone Acetate, which is 0.83% below the labeled claim of 30 mg/ml.
The analysis was conducted on 25 April 2024, following the sample receipt on 24 April 2024.
Detailed Report
Product Information
- Manufacturer: MuscleCandy
- Product Name: Ment (30 mg)
- Active Ingredient: Trestolone Acetate
- Batch Number: Lot 1003
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Processing and Analysis
- Task Number: #41401
- Testing Ordered: 19 April 2024
- Sample Received: 24 April 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: MuscleCandy
- Analysis Paid For By: MuscleCandy
Testing Results
- Claimed Specification: 30 mg/ml
- Measured Concentration: 29.75 mg/ml
- Accuracy: 99.17% (0.83% below label claim)
- Variance: -0.83%
Verification Details
- Verification URL: https://janoshik.com/tests/41401_4LYMT9AU8DGN
Evaluation and Insights
The analysis reveals a minimal deviation of -0.83%, indicating that the detected concentration closely matches the labeled claim. This level of variance is well within acceptable limits, suggesting satisfactory production consistency.
Conclusion
The lab analysis of Ment (30 mg) detected a 29.75 mg/ml concentration of Trestolone Acetate, indicating a -0.83% deviation below the label claim. The result is acceptable and points to accurate manufacturing practices.
Disclaimer
This report is provided for educational and harm reduction purposes. Product submissions may involve inherent biases, and independent verification is recommended for critical evaluations.
